Inhibition of platelet-induced thrombus formation.
D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000378:metabolism*; D001927:Brain Diseases / Q000517:prevention & control; D004176:Dipyridamole / Q000627:therapeutic use*; D004837:Epinephrine / Q000494:pharmacology; D005921:Glomerulonephritis / Q000188:drug therapy; D006350:Heart Valve Prosthesis; D006801:Humans; D006974:Hypertension, Malignant / Q000188:drug therapy; D007511:Ischemia / Q000517:prevention & control; D009203:Myocardial Infarction / Q000517:prevention & control; D010973:Platelet Adhesiveness / Q000187:drug effects; D011183:Postoperative Complications; D011453:Prostaglandins / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013923:Thromboembolism / Q000517:prevention & control; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000517:prevention & control*; D014970:Xanthines / Q000494:pharmacology
D011453:Prostaglandins; D011743:Pyrimidines; D014970:Xanthines; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D000241:Adenosine; D001241:Aspirin; D004837:Epinephrine